FDA
-
-
-
-
-
-
-
IMPLANET Reports Full-Year 2025 Results
-
-
-
-
-
-
-
IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery System
-
-
-
-
-
-
-
IMPLANET Announces 2024 Full-Year Revenue Up 26% to €9.4 Million
-
-
-
-
-
-
-
IMPLANET Reports Revenue of €4.1 Million in the First Half of 2024
-
-
-
-
-
-
-
IMPLANET Reports 2023 Annual Revenue of €7.4 Million
-
-
-
-
-
-
-
IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue
-
-
-
-
-
-
-
IMPLANET Reports Its Q1 2023 Revenue
-
326,111 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

